Bcl-2/bcl-xL bispecific antisense treatment sensitizes breast carcinoma cells to doxorubicin, paclitaxel and cyclophosphamide (Q40687579)
Jump to navigation
Jump to search
scientific article published on November 2002
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Bcl-2/bcl-xL bispecific antisense treatment sensitizes breast carcinoma cells to doxorubicin, paclitaxel and cyclophosphamide |
scientific article published on November 2002 |
Statements
1 reference
Bcl-2/bcl-xL bispecific antisense treatment sensitizes breast carcinoma cells to doxorubicin, paclitaxel and cyclophosphamide (English)
1 reference
A Paula Simões-Wüst
1 reference
Thomas Schürpf
1 reference
Jonathan Hall
1 reference
Rolf A Stahel
1 reference
Uwe Zangemeister-Wittke
1 reference
1 November 2002
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference